newsfilter
← Latest News
PR Newswire·

BioMarin Reports Fourth Quarter and Full-year 2025 Financial and Operating Results

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced financial results for the fourth quarter and full year ended December 31, 2025. "In 2025, ...